Company

Tristel plc

Headquarters: Snailwell, United Kingdom

Employees: 196

CEO: Mr. Paul C. Swinney

LSE: TSTL +0.65%

Market Cap

£219.6 Million

GBP as of July 1, 2024

US$277.8 Million

Market Cap History

Tristel plc market capitalization over time

Evolution of Tristel plc market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Tristel plc

Detailed Description

Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers medical instrument disinfection products, including airway management, cardiology, ear, nose and throat, endoscopy, ophthalmology, phlebotomy, reproductive health/IVF, surface, ultrasound, urology, women's health, and other products under the Tristel brand; contamination control products, which include cleanroom, laboratory, pharmaceutical, cosmetic, and toiletry disinfectants under the Crystel brand; and airborne and veterinary device disinfectants under the Anistel brand. The company was founded in 1993 and is headquartered in Snailwell, the United Kingdom.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

Tristel plc has the following listings and related stock indices.


Stock: LSE: TSTL wb_incandescent

Stock: FSX: R1V wb_incandescent

Details

Headquarters:

Lynx Business Park

Unit 1B Fordham Road Newmarket

Snailwell, CB8 7NY

United Kingdom

Phone: 44 16 3872 1500

Fax: 44 16 3872 1911